Blepharitis is an inflammation of the eyelids in which they become red, irritated and itchy and dandruff-like scales form on the eyelashes. It is a common eye disorder caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. It affects people of all ages. Although uncomfortable, blepharitis is usually not contagious and generally does not cause any permanent damage to eyesight.

Market competition is intense. Bausch Health, Allergan, Novartis LABORATORIES THEA, etc. are the leaders of the industry. They hold key technologies and patents, with high-end customers, but only occupied 24.39% market share.

Market Analysis and Insights: Global Blepharitis Market

The global Blepharitis market size is projected to reach US$ 1942.7 million by 2026, from US$ 1444.4 million in 2019, at a CAGR of 4.3% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blepharitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blepharitis market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blepharitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blepharitis market.

Blepharitis Breakdown Data by Type

• Antibiotics
• Steroids
• Other

The classification of blepharitis includes Antibiotics, Steroids and Other and the revenue proportion of Antibiotics in 2019 is about 62.72%.

Blepharitis Breakdown Data by Application

• Monotherapy
• Combination Drug Therapy

Blepharitis are widely used for Monotherapy and Combination Drug Therapy. Monotherapy was the largest revenue generating segment in 2019, and the revenue market share is about 69.89%.

Based on regional and country-level analysis, the Blepharitis market has been segmented as follows:

North America

• United States
• Canada

Europe

• Germany
• France
• UK.
• Italy
• Russia
• Nordic
• Rest of Europe

Asia-Pacific

• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific

Latin America

• Mexico
• Brazil

Middle East & Africa

• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Blepharitis market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:

• Bausch Health
• Allergan
• Novartis
• LABORATORIES THEA
• Akorn
• NovaBay Pharmaceuticals
• Scope Ophthalmics

List of Tables
Table 1. Global Blepharitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Antibiotics

Table 3. Key Players of Steroids

Table 4. Key Players of Other

Table 5. Global Blepharitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 6. Global Blepharitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 7. Global Blepharitis Market Size by Regions (2016-2021) & (US$ Million)

Table 8. Global Blepharitis Market Share by Regions (2016-2021)

Table 9. Global Blepharitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 10. Global Blepharitis Market Share by Regions (2022-2027)

Table 11. Blepharitis Market Trends

Table 12. Blepharitis Market Drivers

Table 13. Blepharitis Market Challenges

Table 14. Blepharitis Market Restraints

Table 15. Global Blepharitis Revenue by Players (2016-2021) & (US$ Million)

Table 16. Global Blepharitis Market Share by Players (2016-2021)

Table 17. Global Top Blepharitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blepharitis as of 2020)

Table 18. Ranking of Global Top Blepharitis Companies by Revenue (US$ Million) in 2020

Table 19. Global 5 Largest Players Market Share by Blepharitis Revenue (CR5 and HHI) & (2016-2021)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Blepharitis Product Solution and Service

Table 22. Date of Enter into Blepharitis Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Blepharitis Market Size by Type (2016-2021) (US$ Million)

Table 25. Global Blepharitis Revenue Market Share by Type (2016-2021)

Table 26. Global Blepharitis Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 27. Global Blepharitis Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 28. Global Blepharitis Market Size Share by Application (2016-2021) & (US$ Million)

Table 29. Global Blepharitis Revenue Market Share by Application (2016-2021)

Table 30. Global Blepharitis Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 31. Global Blepharitis Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 32. North America Blepharitis Market Size by Type (2016-2021) (US$ Million)

Table 33. North America Blepharitis Market Size by Type (2022-2027) & (US$ Million)

Table 34. North America Blepharitis Market Size by Application (2016-2021) (US$ Million)

Table 35. North America Blepharitis Market Size by Application (2022-2027) & (US$ Million)

Table 36. North America Blepharitis Market Size by Country (2016-2021) & (US$ Million)

Table 37. North America Blepharitis Market Size by Country (2022-2027) & (US$ Million)

Table 38. Europe Blepharitis Market Size by Type (2016-2021) (US$ Million)

Table 39. Europe Blepharitis Market Size by Type (2022-2027) & (US$ Million)

Table 40. Europe Blepharitis Market Size by Application (2016-2021) (US$ Million)

Table 41. Europe Blepharitis Market Size by Application (2022-2027) & (US$ Million)

Table 42. Europe Blepharitis Market Size by Country (2016-2021) & (US$ Million)

Table 43. Europe Blepharitis Market Size by Country (2022-2027) & (US$ Million)

Table 44. Asia-Pacific Blepharitis Market Size by Type (2016-2021) (US$ Million)

Table 45. Asia-Pacific Blepharitis Market Size by Type (2022-2027) & (US$ Million)

Table 46. Asia-Pacific Blepharitis Market Size by Application (2016-2021) (US$ Million)

Table 47. Asia-Pacific Blepharitis Market Size by Application (2022-2027) & (US$ Million)

Table 48. Asia-Pacific Blepharitis Market Size by Region (2016-2021) & (US$ Million)

Table 49. Asia-Pacific Blepharitis Market Size by Region (2022-2027) & (US$ Million)

Table 50. Latin America Blepharitis Market Size by Type (2016-2021) (US$ Million)

Table 51. Latin America Blepharitis Market Size by Type (2022-2027) & (US$ Million)

Table 52. Latin America Blepharitis Market Size by Application (2016-2021) (US$ Million)

Table 53. Latin America Blepharitis Market Size by Application (2022-2027) & (US$ Million)

Table 54. Latin America Blepharitis Market Size by Country (2016-2021) & (US$ Million)

Table 55. Latin America Blepharitis Market Size by Country (2022-2027) & (US$ Million)

Table 56. Middle East & Africa Blepharitis Market Size by Type (2016-2021) (US$ Million)

Table 57. Middle East & Africa Blepharitis Market Size by Type (2022-2027) & (US$ Million)

Table 58. Middle East & Africa Blepharitis Market Size by Application (2016-2021) (US$ Million)

Table 59. Middle East & Africa Blepharitis Market Size by Application (2022-2027) & (US$ Million)

Table 60. Middle East & Africa Blepharitis Market Size by Country (2016-2021) & (US$ Million)

Table 61. Middle East & Africa Blepharitis Market Size by Country (2022-2027) & (US$ Million)

Table 62. Bausch Health Company Details

Table 63. Bausch Health Business Overview

Table 64. Bausch Health Blepharitis Product

Table 65. Bausch Health Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 66. Bausch Health Recent Development

Table 67. Allergan Company Details

Table 68. Allergan Business Overview

Table 69. Allergan Blepharitis Product

Table 70. Allergan Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 71. Allergan Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Blepharitis Product

Table 75. Novartis Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. LABORATORIES THEA Company Details

Table 78. LABORATORIES THEA Business Overview

Table 79. LABORATORIES THEA Blepharitis Product

Table 80. LABORATORIES THEA Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 81. LABORATORIES THEA Recent Development

Table 82. Akorn Company Details

Table 83. Akorn Business Overview

Table 84. Akorn Blepharitis Product

Table 85. Akorn Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 86. Akorn Recent Development

Table 87. NovaBay Pharmaceuticals Company Details

Table 88. NovaBay Pharmaceuticals Business Overview

Table 89. NovaBay Pharmaceuticals Blepharitis Product

Table 90. NovaBay Pharmaceuticals Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 91. NovaBay Pharmaceuticals Recent Development

Table 92. Scope Ophthalmics Company Details

Table 93. Scope Ophthalmics Business Overview

Table 94. Scope Ophthalmics Blepharitis Product

Table 95. Scope Ophthalmics Revenue in Blepharitis Business (2016-2021) & (US$ Million)

Table 96. Scope Ophthalmics Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Blepharitis Market Share by Type: 2020 VS 2027

Figure 2. Antibiotics Features

Figure 3. Steroids Features

Figure 4. Other Features

Figure 5. Global Blepharitis Market Share by Application: 2020 VS 2027

Figure 6. Monotherapy Case Studies

Figure 7. Combination Drug Therapy Case Studies

Figure 8. Blepharitis Report Years Considered

Figure 9. Global Blepharitis Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 10. Global Blepharitis Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 11. Global Blepharitis Market Share by Regions: 2020 VS 2027

Figure 12. Global Blepharitis Market Share by Regions (2022-2027)

Figure 13. Global Blepharitis Market Share by Players in 2020

Figure 14. Global Top Blepharitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blepharitis as of 2020

Figure 15. The Top 10 and 5 Players Market Share by Blepharitis Revenue in 2020

Figure 16. Global Blepharitis Revenue Market Share by Type (2016-2021)

Figure 17. Global Blepharitis Revenue Market Share by Type (2022-2027)

Figure 18. North America Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 19. North America Blepharitis Market Share by Type (2016-2027)

Figure 20. North America Blepharitis Market Share by Application (2016-2027)

Figure 21. North America Blepharitis Market Share by Country (2016-2027)

Figure 22. United States Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 23. Canada Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 24. Europe Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 25. Europe Blepharitis Market Share by Type (2016-2027)

Figure 26. Europe Blepharitis Market Share by Application (2016-2027)

Figure 27. Europe Blepharitis Market Share by Country (2016-2027)

Figure 28. Germany Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 29. France Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 30. U.K. Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. Italy Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. Russia Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 33. Nordic Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 34. Asia-Pacific Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 35. Asia-Pacific Blepharitis Market Share by Type (2016-2027)

Figure 36. Asia-Pacific Blepharitis Market Share by Application (2016-2027)

Figure 37. Asia-Pacific Blepharitis Market Share by Region (2016-2027)

Figure 38. China Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 39. Japan Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 40. South Korea Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Southeast Asia Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. India Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 43. Australia Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 44. Latin America Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 45. Latin America Blepharitis Market Share by Type (2016-2027)

Figure 46. Latin America Blepharitis Market Share by Application (2016-2027)

Figure 47. Latin America Blepharitis Market Share by Country (2016-2027)

Figure 48. Mexico Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 49. Brazil Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 50. Middle East & Africa Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Middle East & Africa Blepharitis Market Share by Type (2016-2027)

Figure 52. Middle East & Africa Blepharitis Market Share by Application (2016-2027)

Figure 53. Middle East & Africa Blepharitis Market Share by Country (2016-2027)

Figure 54. Turkey Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 55. Saudi Arabia Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 56. UAE Blepharitis Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Bausch Health Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 58. Allergan Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 59. Novartis Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 60. LABORATORIES THEA Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 61. Akorn Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 62. NovaBay Pharmaceuticals Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 63. Scope Ophthalmics Revenue Growth Rate in Blepharitis Business (2016-2021)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Blepharitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Antibiotics
        1.2.3 Steroids
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Blepharitis Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Monotherapy
        1.3.3 Combination Drug Therapy
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Blepharitis Market Perspective (2016-2027)
    2.2 Blepharitis Growth Trends by Regions
        2.2.1 Blepharitis Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Blepharitis Historic Market Share by Regions (2016-2021)
        2.2.3 Blepharitis Forecasted Market Size by Regions (2022-2027)
    2.3 Blepharitis Industry Dynamic
        2.3.1 Blepharitis Market Trends
        2.3.2 Blepharitis Market Drivers
        2.3.3 Blepharitis Market Challenges
        2.3.4 Blepharitis Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Blepharitis Players by Revenue
        3.1.1 Global Top Blepharitis Players by Revenue (2016-2021)
        3.1.2 Global Blepharitis Revenue Market Share by Players (2016-2021)
    3.2 Global Blepharitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Blepharitis Revenue
    3.4 Global Blepharitis Market Concentration Ratio
        3.4.1 Global Blepharitis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Blepharitis Revenue in 2020
    3.5 Blepharitis Key Players Head office and Area Served
    3.6 Key Players Blepharitis Product Solution and Service
    3.7 Date of Enter into Blepharitis Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Blepharitis Breakdown Data by Type
    4.1 Global Blepharitis Historic Market Size by Type (2016-2021)
    4.2 Global Blepharitis Forecasted Market Size by Type (2022-2027)

5 Blepharitis Breakdown Data by Application
    5.1 Global Blepharitis Historic Market Size by Application (2016-2021)
    5.2 Global Blepharitis Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Blepharitis Market Size (2016-2027)
    6.2 North America Blepharitis Market Size by Type
        6.2.1 North America Blepharitis Market Size by Type (2016-2021)
        6.2.2 North America Blepharitis Market Size by Type (2022-2027)
        6.2.3 North America Blepharitis Market Size by Type (2016-2027)
    6.3 North America Blepharitis Market Size by Application
        6.3.1 North America Blepharitis Market Size by Application (2016-2021)
        6.3.2 North America Blepharitis Market Size by Application (2022-2027)
        6.3.3 North America Blepharitis Market Size by Application (2016-2027)
    6.4 North America Blepharitis Market Size by Country
        6.4.1 North America Blepharitis Market Size by Country (2016-2021)
        6.4.2 North America Blepharitis Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Blepharitis Market Size (2016-2027)
    7.2 Europe Blepharitis Market Size by Type
        7.2.1 Europe Blepharitis Market Size by Type (2016-2021)
        7.2.2 Europe Blepharitis Market Size by Type (2022-2027)
        7.2.3 Europe Blepharitis Market Size by Type (2016-2027)
    7.3 Europe Blepharitis Market Size by Application
        7.3.1 Europe Blepharitis Market Size by Application (2016-2021)
        7.3.2 Europe Blepharitis Market Size by Application (2022-2027)
        7.3.3 Europe Blepharitis Market Size by Application (2016-2027)
    7.4 Europe Blepharitis Market Size by Country
        7.4.1 Europe Blepharitis Market Size by Country (2016-2021)
        7.4.2 Europe Blepharitis Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Blepharitis Market Size (2016-2027)
    8.2 Asia-Pacific Blepharitis Market Size by Type
        8.2.1 Asia-Pacific Blepharitis Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Blepharitis Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Blepharitis Market Size by Type (2016-2027)
    8.3 Asia-Pacific Blepharitis Market Size by Application
        8.3.1 Asia-Pacific Blepharitis Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Blepharitis Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Blepharitis Market Size by Application (2016-2027)
    8.4 Asia-Pacific Blepharitis Market Size by Region
        8.4.1 Asia-Pacific Blepharitis Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Blepharitis Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Blepharitis Market Size (2016-2027)
    9.2 Latin America Blepharitis Market Size by Type
        9.2.1 Latin America Blepharitis Market Size by Type (2016-2021)
        9.2.2 Latin America Blepharitis Market Size by Type (2022-2027)
        9.2.3 Latin America Blepharitis Market Size by Type (2016-2027)
    9.3 Latin America Blepharitis Market Size by Application
        9.3.1 Latin America Blepharitis Market Size by Application (2016-2021)
        9.3.2 Latin America Blepharitis Market Size by Application (2022-2027)
        9.3.3 Latin America Blepharitis Market Size by Application (2016-2027)
    9.4 Latin America Blepharitis Market Size by Country
        9.4.1 Latin America Blepharitis Market Size by Country (2016-2021)
        9.4.2 Latin America Blepharitis Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Blepharitis Market Size (2016-2027)
    10.2 Middle East & Africa Blepharitis Market Size by Type
        10.2.1 Middle East & Africa Blepharitis Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Blepharitis Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Blepharitis Market Size by Type (2016-2027)
    10.3 Middle East & Africa Blepharitis Market Size by Application
        10.3.1 Middle East & Africa Blepharitis Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Blepharitis Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Blepharitis Market Size by Application (2016-2027)
    10.4 Middle East & Africa Blepharitis Market Size by Country
        10.4.1 Middle East & Africa Blepharitis Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Blepharitis Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bausch Health
        11.1.1 Bausch Health Company Details
        11.1.2 Bausch Health Business Overview
        11.1.3 Bausch Health Blepharitis Introduction
        11.1.4 Bausch Health Revenue in Blepharitis Business (2016-2021)
        11.1.5 Bausch Health Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Details
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Blepharitis Introduction
        11.2.4 Allergan Revenue in Blepharitis Business (2016-2021)
        11.2.5 Allergan Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Blepharitis Introduction
        11.3.4 Novartis Revenue in Blepharitis Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 LABORATORIES THEA
        11.4.1 LABORATORIES THEA Company Details
        11.4.2 LABORATORIES THEA Business Overview
        11.4.3 LABORATORIES THEA Blepharitis Introduction
        11.4.4 LABORATORIES THEA Revenue in Blepharitis Business (2016-2021)
        11.4.5 LABORATORIES THEA Recent Development
    11.5 Akorn
        11.5.1 Akorn Company Details
        11.5.2 Akorn Business Overview
        11.5.3 Akorn Blepharitis Introduction
        11.5.4 Akorn Revenue in Blepharitis Business (2016-2021)
        11.5.5 Akorn Recent Development
    11.6 NovaBay Pharmaceuticals
        11.6.1 NovaBay Pharmaceuticals Company Details
        11.6.2 NovaBay Pharmaceuticals Business Overview
        11.6.3 NovaBay Pharmaceuticals Blepharitis Introduction
        11.6.4 NovaBay Pharmaceuticals Revenue in Blepharitis Business (2016-2021)
        11.6.5 NovaBay Pharmaceuticals Recent Development
    11.7 Scope Ophthalmics
        11.7.1 Scope Ophthalmics Company Details
        11.7.2 Scope Ophthalmics Business Overview
        11.7.3 Scope Ophthalmics Blepharitis Introduction
        11.7.4 Scope Ophthalmics Revenue in Blepharitis Business (2016-2021)
        11.7.5 Scope Ophthalmics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details